Clinical Trials Directory

Trials / Sponsors / OcuNexus Therapeutics, Inc.

OcuNexus Therapeutics, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a D
Diabetic Foot Ulcers
Phase 22012-07-01
CompletedA Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects W
Venous Leg Ulcers
Phase 22011-05-01
TerminatedThe ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabe
Diabetic Foot Ulcer
Phase 1 / Phase 22009-04-01
WithdrawnA Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects
Persistent Epithelial Defect
Phase 22009-03-01
CompletedA Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)
Venous Ulcer
Phase 22009-03-01
CompletedA Study Evaluating Nexagon™ in the Treatment of Skin Wounds.
Wound Healing
Phase 12008-09-01
CompletedA Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surge
Corneal re-Epithelialization
Phase 12008-04-01